Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/12458
|
| Title: | Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia fungal working group (AFWG) survey |
| Authors: | Tan, BH;Chakrabarti, A;Patel, A;Chua, MMM;Sun, PL;Liu, Z;Rotjanapan, P;Li, R;Wahyuningsih, R;Chayakulkeeree, M;Chen, YC |
| Contributors: | National Institute of Infectious Diseases and Vaccinology |
| Abstract: | BACKGROUND: Invasive fungal diseases (IFD) are a serious threat, but physicians in Asia lack access to many advanced diagnostics in mycology. It is likely that they face other impediments in the management of IFD. A gap analysis was performed to understand the challenges Asian physicians faced in medical mycology. METHODS: The Asia Fungal Working Group (AFWG) conducted a web-based survey on management practices for IFD among clinicians in China, India, Indonesia, Philippines, Singapore, Taiwan and Thailand. FINDINGS: Among 292 respondents, 51.7% were infectious disease (ID) specialists. Only 37% of respondents had received formal training in medical mycology. They handled only around 2-4 proven cases of each fungal infection monthly, with invasive candidiasis the most common. For laboratory support, the majority had access to direct microscopy (96%) and histopathology (87%), but galactomannan and azole levels were available to 60% and 25% of respondents, respectively. The majority (84%) used clinical parameters for treatment response monitoring, and 77% followed the Infectious Diseases Society of America guidelines. The majority (84%) did not use the services of an ID physician. Where febrile neutropenia was concerned, 74% of respondents used the empirical approach. Only 30% had an antifungal stewardship program in their hospital. Eighty percent could not use preferred antifungals because of cost. INTERPRETATION: The survey identified inadequacies in medical mycology training, non-culture diagnostics, access to antifungal drugs, and local guidelines as the major gaps in the management of IFDs in Asian countries. These gaps are targets for improvement. |
| Date: | 2020-06 |
| Relation: | International Journal of Infectious Diseases. 2020 Jun;95:471-480. |
| Link to: | http://dx.doi.org/10.1016/j.ijid.2020.01.007 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1201-9712&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000540737100088 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85081218232 |
| Appears in Collections: | [陳宜君] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB31945491.pdf | | 3278Kb | Adobe PDF | 389 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
